Added to YB: 2022-05-02
Pitch date: 2022-05-02
CTLT [bullish]
Catalent, Inc.
-32.27%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide.
Market Cap
$11.5B
Pitch Price
$93.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
31.44
P/E
-27.83
EV/Sales
3.65
Sector
Pharmaceuticals
Category
N/A
Show full summary:
CATALENT INC CTLT
A summary for this pitch has not been created yet.
Read full article (0 min)